These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3751419)

  • 61. [Cerebral hemodynamic function in patients with the initial manifestations of brain blood supply failure under the influence of pelotherapy combined with the electrophoresis of vasoactive preparations].
    Musaev AV; Balakishieva FK
    Vopr Kurortol Fizioter Lech Fiz Kult; 1991; (4):13-6. PubMed ID: 1792718
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Drug resistance in epilepsy].
    Rabending G; Scherber A
    Z Arztl Fortbild (Jena); 1990; 84(15):761-6. PubMed ID: 2267815
    [No Abstract]   [Full Text] [Related]  

  • 63. Potentiation of the anticonvulsant effects of antiepileptic drugs by "nootropics"; a potential new therapeutic approach.
    Mondadori C; Schmutz M; Baltzer V
    Acta Neurol Scand Suppl; 1984; 99():131-2. PubMed ID: 6430020
    [No Abstract]   [Full Text] [Related]  

  • 64. [Efficacy of cavinton in the treatment of patients with chronic blood flow insufficiency. Russian multicenter clinical-epidemiological program "CALIPSO"].
    Chukanova EI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(12):49-52. PubMed ID: 21311488
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Blood flow insufficiency in vertebrobasilar system].
    Sitel' AB; Teterina EB
    Zh Nevrol Psikhiatr Im S S Korsakova; 2003; 103(8):11-7. PubMed ID: 14564771
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [The multimodal strategy for the neuroprotection in stroke: results of the Russian multicenter clinical-epidemiological program SOKOL].
    Tabeeva GR; Azimova IuE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(12 Pt 2):20-30. PubMed ID: 23388602
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Cavinton forte treatment of cerebral vascular insufficiency in patients with coronary heart disease and arterial hypertension].
    Protasov KV; Dzizinskiĭ AA; Shprakh VV; Sinkevich DA; Kuklin SG; Filatova LN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(7):31-4. PubMed ID: 16921716
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Use of cavinton in neuropaediatrics].
    Studenikin VM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(12):63-4. PubMed ID: 15847328
    [No Abstract]   [Full Text] [Related]  

  • 69. [Effect of ethyl ether of apovincaminic acid (Cavinton) on the ototoxic action of sisomicin in guinea pigs].
    Kosztyła-Hojna B
    Otolaryngol Pol; 1990; 44(2):122-9. PubMed ID: 2216503
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Complex treatment of epilepsy with phenotropil].
    Bel'skaia GN; Ponomareva IV; Lukashevich IG; Tikhomirova IN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(8):40-3. PubMed ID: 18379471
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Experience with the use of cavinton in the treatment of patients with incipient senile atherosclerotic encephalopathy].
    Man'kovskiĭ NB; Mints AIa; Karaban' IN; Litvinenko AA; Bachinskaia NIu
    Vrach Delo; 1987 Jan; (1):46-9. PubMed ID: 3564418
    [No Abstract]   [Full Text] [Related]  

  • 72. [Inclusion of flunarizine in the antiepileptic drug protocol. Clinical and laboratory observations].
    De Romanis F; Sopranzi N
    Clin Ter; 1987 Dec; 123(6):465-8. PubMed ID: 2972504
    [No Abstract]   [Full Text] [Related]  

  • 73. [A multicenter program on assessment of efficacy and safety of a new therapeutic scheme for patients with chronic cerebrovascular insufficiency].
    Skoromets AA; Tanashian MM; Chukanova EI; Petrova EA; Spirin NN; Nikonov AA; Peverennova IE; Levin IaI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(5 Suppl 2):44-8. PubMed ID: 19894300
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Psychoactive effect of vincamine in a group of subjects affected by recurrent depressive syndrome. Preliminary note].
    Crispi G; Di Lorenzo RS; Gentile A; Florino A; Pannone B; Sciorio G
    Minerva Med; 1975 Oct; 66(70):3683-5. PubMed ID: 1103012
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effectivity of Cavinton and Lucidril in the treatment of hearing defects of different origin.
    Jasper A
    Ther Hung; 1979; 27(1):29-31. PubMed ID: 386551
    [No Abstract]   [Full Text] [Related]  

  • 76. [The neurotropic action of kavinton].
    Trepakov VV; Buldakova SL; Latanov AV; Saakian SA; Iashchenko EA
    Farmakol Toksikol; 1987; 50(4):29-33. PubMed ID: 3499349
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Polymorphic effects of cavinton: experimental and clinical evidence].
    Kasatkin DS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(9 Pt 2):8-12. PubMed ID: 21465683
    [No Abstract]   [Full Text] [Related]  

  • 78. [The use of cavinton in the therapy of cognitive disorders in patients with discirculatory encephalopathy].
    Odinak MM; Lobzin VIu
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(10):63-4. PubMed ID: 20213894
    [No Abstract]   [Full Text] [Related]  

  • 79. [Results using Cavinton in various diseases of the central nervous system in children].
    Ignatowicz R; Michałowicz R; Kmieć T
    Wiad Lek; 1986 Aug; 39(16):1101-5. PubMed ID: 3548072
    [No Abstract]   [Full Text] [Related]  

  • 80. Use of ethyl apovincaminate in ophthalmological therapy.
    Kahán A; Oláh M
    Arzneimittelforschung; 1976; 26(10a):1969-72. PubMed ID: 1037225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.